Loading the company…
Loading the company…
In 2025, Xiros reported engagement with 2 surgeons and other clinicians in the states MedaRep covers, worth $11K in consulting, speaking, meals and travel for its device products, the most in Arizona ($9,755 to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Arizona ($9,755, 1 engaged), Texas ($1,575, 1 engaged).
In the last ten years FDA made 5 decisions for Xiros (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2022 (2). The latest was on 2023-05-31.
| Family | Decisions on record |
|---|---|
| Hernia repair | 3 |
| Xtreme-Loop |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Xiros.